Clinical Trial Update: Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda [Phase 4]

View source ↗

Summary

Phase 4 trial of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in Uganda has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria in Pregnancy
• Placental Malaria

Drugs mentioned

• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Intermittent Preventive Treatment, Placental Malaria | Phase 4 | Status: WITHDRAWN